These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5325404)

  • 41. [The use of a non-steroid topical anti-inflammatory agent in dermatological therapy].
    Landini Lascialfare U
    Policlinico Med; 1969; 76(5):285-90. PubMed ID: 5362416
    [No Abstract]   [Full Text] [Related]  

  • 42. [Emovate in pediatric practice. A Swiss study on a new local corticosteroid].
    Graber W; Miescher A; Schneider HJ
    Ther Umsch; 1983 May; 40(5):449-53. PubMed ID: 6346567
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experiences with the local application of a synthetic tar-corticoid preparation].
    Berg M
    Z Haut Geschlechtskr; 1968 Mar; 43(6):255-8. PubMed ID: 5672428
    [No Abstract]   [Full Text] [Related]  

  • 44. Topical conjunctival corticosteroid therapy for malignant atrophic papulosis (Kohlmeier-Degos disease).
    Orellana J; Friedman AH
    Mt Sinai J Med; 1983; 50(1):90-4. PubMed ID: 6601770
    [No Abstract]   [Full Text] [Related]  

  • 45. [1.0 percent alcinonide ointment, a new topical corticosteroid preparation: clinico-therapeutic evaluation].
    Ponzio F; Scalese A; Spagnoli U
    Clin Ter; 1980 May; 93(3):295-309. PubMed ID: 7449343
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic evaluation of Chlotaon tablets, a combination antibiotic, for use in acute otorhinolaryngologic infections].
    Iwasawa T
    Jibiinkoka; 1966 Sep; 38(9):987-97. PubMed ID: 5341372
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents].
    Michałowski R; Kuczyńska L
    Przegl Dermatol; 1981; 68(2):227-32. PubMed ID: 7029660
    [No Abstract]   [Full Text] [Related]  

  • 48. [A new principle for topical corticosteroid treatment].
    Hagerman G
    Lakartidningen; 1965 Sep; 62(37):2951-4. PubMed ID: 5330647
    [No Abstract]   [Full Text] [Related]  

  • 49. [Betamethasone-17-valerate for topical use in dermatologic therapy].
    Avellino M
    Riforma Med; 1965 Jul; 79(28):762-4. PubMed ID: 5836403
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical trial of a steroid derivative (9-alpha-fluoro-prednisolone-21-acetate) in association with aqueous extract of althea in the dermatological field].
    Piovano PB; Mazzocchi S
    G Ital Dermatol Minerva Dermatol; 1970 Apr; 45(4):279-86. PubMed ID: 5537593
    [No Abstract]   [Full Text] [Related]  

  • 51. [Preliminary results with a new corticosteroid for topical use].
    de Abreu JG
    Hospital (Rio J); 1970 Apr; 77(4):1197-200. PubMed ID: 4939508
    [No Abstract]   [Full Text] [Related]  

  • 52. [Thalidomide and thrombosis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2003 Apr; 130(4):489. PubMed ID: 12843869
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of topical steroids on corneal epithelial healing after vitreoretinal surgery.
    Yülek F; Ozdek S; Gürelik G; Hasanreisoğlu B
    Acta Ophthalmol Scand; 2006 Jun; 84(3):319-22. PubMed ID: 16704691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risks of unoccluded topical steroids in clinical trials.
    Akers WA
    Arch Dermatol; 1980 Jul; 116(7):786-8. PubMed ID: 6994659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experiences with a potent new corticosteroid ester for dermatoses. Report describing a preliminary clinical study of bethamethasone, a new, active topical corticosteroid.
    Luscombe HA
    Pa Med; 1966 Oct; 69(10):48-9. PubMed ID: 5950551
    [No Abstract]   [Full Text] [Related]  

  • 56. [1st experiences with a new topical therapeutic agent].
    Beck W
    Med Welt; 1972 Sep; 23(36):1230-1. PubMed ID: 4562538
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diucifon in the therapy of dermatoses].
    Grebeniuk VN; Fedorova EG; Sheklakova MN
    Vestn Dermatol Venerol; 1980 Feb; (2):41-3. PubMed ID: 6986724
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of skin diseases with a combined antiinfection and antiinflammatory gel (Exosterol) (author's transl)].
    Hofer P
    Schweiz Rundsch Med Prax; 1974 Dec; 63(51):1550-3. PubMed ID: 4438269
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 60. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U; Hansel G; Koch A; Abdel-Naser MB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.